Global Cerebral/Somatic Oximetry Market Size to Reach USD 399.6 Million in 2032 | Emergen Research

Vancouver, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The global market for Cerebral/Somatic Oximetry, which measures oxygen levels, reached a value of USD 202 million in 2022. Based on the latest analysis conducted by Emergen Research, it is anticipated to experience a 7.0% compound annual growth rate (CAGR) in terms of revenue during the projected period. This growth is primarily attributed to the increasing adoption of cerebral oximeters, the rise in occurrences of neurological disorders, and ongoing advancements in healthcare technology.

The utilization of cerebral oximeters in combination with noninvasive blood pressure measurement and mean arterial pressure offers a more precise evaluation of cerebral desaturation. These oximeters gauge the oxygen content within tissues and also quantify the hemoglobin levels present in the arteries, veins, and capillaries of the blood. Notably, about 70% of average tissue hemoglobin in the cerebral cortex is found in venous blood, while the remaining 30% is located in arterial blood.

You Can Download Free Sample PDF Copy Of This Report@  https://www.emergenresearch.com/request-sample/2206

Cerebral oximetry plays a crucial role in the treatment of patients dealing with severe brain damage. It exhibits a heightened sensitivity compared to Computed Tomography (CT) scans, enabling the detection of cerebral hematomas. In the realm of cardiac surgery, the application of Near-Infrared Spectroscopy (NIRS) has been extensively studied. Notably, research has revealed that incorporating cerebral oximetry-guided cardiac anesthesia, particularly in scenarios involving cardiopulmonary bypass, correlates with reduced stays in critical care units, as well as significantly lower mortality and morbidity rates.

A proactive approach to addressing low regional cerebral Oxygen Saturation (rSO2) levels has yielded noteworthy outcomes, including the reduction of postoperative cognitive impairment occurrences and the prevention of prolonged cerebral desaturation. This has in turn contributed to the expansion of the market's revenue.

However, somatic monitoring presents a more intricate challenge due to the nature of Near-Infrared (NIR) light penetration. When applied to the body's surface, NIR light can permeate potentially dense muscle and fascial layers, necessitating adjustments to ensure accurate measurements at shallower levels.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/2206

Scope of Research

Major Companies and Competitive Landscape

The global cerebral/somatic oximetry market is fairly fragmented, with a number of large and medium-sized players accounting for the majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective solutions. Some major companies included in the global cerebral/somatic oximetry market report are:

• Medtronic
• Nonin.
• Edwards Lifesciences Corporation
• ISS, Inc
• Masimo
• Hamamatsu Photonics K.K
• Mespere LifeSciences.
• G.E. Healthcare.
• Terumo Cardiovascular Systems Corporation
• clinocarecr 

Strategic Development

• On 14 December 2021, Medtronic plc, a worldwide leader in healthcare technology, claimed that the U.S. Food and Drug Administration (FDA) has awarded 510(k) clearance for its INVOSTM 7100 cerebral/somatic oximetry system for children aged birth to 18.

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/2206

Some Key Highlights From the Report

• The cardiac surgery segment accounted for a significantly large revenue share in 2022. Cerebral oximetry, a non-invasive monitor, has been utilized as an indicator of cerebral perfusion in cardiac surgery for many years. Research indicates that patients with lower cerebral oxygen saturation levels experience worse outcomes. Cerebral oximetry is considered a potential early warning monitor for changes in oxygenation, ventilation, mixed venous oxygen saturation, and cardiac output. It has proven effective in detecting vulnerable periods during cardiac surgery. Near-Infrared Spectroscopy (NIRS) is the technology used in these oximeters and has been demonstrated to be extremely safe., hence driving revenue growth of this segment.   
• The hospitals & clinics segment accounted for largest revenue share in 2022. Most people visit hospitals and clinics as they have access to specialists and facilities to perform heart-related surgeries. According to an article published by the AJMC in February 2021, around 8,273,270 hospitalizations were reported for heart failure during the forecasted period. Cerebral oximeters are mostly used in operating room and intensive care unit departments of the hospital to monitor cerebral desaturation in patients. Therefore, the increasing number of hospital and clinic visits is expected to drive revenue growth of this segment.
• The market in North America accounted for largest revenue share in 2022. The presence and product portfolios of major companies such as Medtronic, Edwards Lifesciences Corporation, Nonin, and Masimo in this region are driving revenue growth of the market. To monitor cerebral desaturation during heart surgery, these businesses provide O3 to oximeter devices such as INVOS System, ForeSight System, EQUANOX, and Root in the United States. These monitoring tools can be used in Operating Rooms (OR), Intensive Care Units (ICU), and Extracorporeal Membrane Oxygenation (ECMO). Research initiatives targeted at creating new cerebral oximeter devices are therefore expected to drive market revenue growth.   

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/cerebral-somatic-oximetry-market   

Emergen Research has segmented the global cerebral/somatic oximetry market on the basis of type, patient type, application, end-use, and region:

• Type Outlook (Revenue, USD Million; 2019-2032)
  • Dual Emitter and Dual Detector
  • Single Emitter and Dual Detector
  • Other Types
• Patient Type Outlook (Revenue, USD Million; 2019-2032)
  • Pediatrics
  • Adults
• Application Outlook (Revenue, USD Million; 2019-2032)
  • Cardiac Surgery
  • Vascular Surgery
  • Other Applications
• End-use Outlook (Revenue, USD Million; 2019-2032)
  • Hospital & Clinics
  • Ambulatory Surgical Centers

• • Other End-use

• Regional Outlook (Revenue, USD Million; 2019-2032)
  • North America
    1. U.S.
    2. Canada
    3. Mexico
  • Europe
    1. Germany
    2. France
    3. U.K.
    4. Italy
    5. Spain
    6. Benelux
    7. Rest of Europe
  • Asia Pacific
    1. China
    2. India
    3. Japan
    4. South Korea
    5. Rest of APAC
  • Latin America
    1. Brazil
    2. Rest of LATAM
  • Middle East & Africa
    1. Saudi Arabia
    2. UAE
    3. South Africa
    4. Turkey
    5. Rest of MEA

Curated Reports You Shouldn't Miss: Dive In Now!

Minimally Invasive Biopsy Technologies Market By Technology (Liquid Biopsy, Optical Biopsy, Pigmented Lesion Assays), By Therapeutic Application (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer), and By End-Use Verticals (Hospitals & Clinics, ASC), Forecasts to 2027

Next Generation Sequencing Sample Preparation Market By Workflow (NGS Library Preparation Kit, Semi-Automated Library Preparation, Automated Library Preparation, Colonial Amplification), By Application, By End-Users, Forecasts to 2027

Pharmacovigilance Market, By Type (Spontaneous Monitoring, Intensified ADR Monitoring, and Others), By Service Provider, By Product Life Cycle, By End-Use, and By Region Forecast to 2030

Stem Cell Therapy Market By Type (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), By Application (Regenerative Medicine, Drug discovery & development), By End-Users (Clinics, Hospitals), and By Region, Forecasts to 2027

Wearable Organs Market Size, Share, Trends, By Product (Kidney, Pancreas, Cochlear implants, Exoskeleton, Bionic Limbs, Vision Bionics), By Technology (Electronic, Mechanical), By Application (Organ Replication, Organ Efficacy, Clinical Testing), Forecasts to 2027

Pharmacogenomics Market By Offering (Hardware, Software, Services), By Technology (Machine Learning, Natural Language Processing (NLP), Context-Aware Computing), By End-User Industry (Healthcare, Manufacturing, Agriculture, Automotive), and By Region, Forecasts to 2027

Sports Medicine Market By Product (Body Reconstruction Products, Body Support and Recovery Products), By Application (Knee Injuries, Shoulder Injuries, Foot and Ankle Injuries), By Body Monitoring and Evaluation Devices, By End-Use, and By Region, and By Region, Forecasts to 2027

 About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights

Read our Press Release @ https://www.emergenresearch.com/press-release/global-cerebral-and-somatic-oximetry-market